Cargando…
The Quest for a Simple Bioactive Analog of Paclitaxel as a Potential Anticancer Agent
[Image: see text] Paclitaxel (PTX), introduced into the clinic in 1991, has revealed itself as an effective antimicrotubule drug for treatment of a range of otherwise intractable cancers. Along with docetaxel (DTX) and in combination with other agents such as cisplatin, it has proven to be a first-l...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
American Chemical
Society
2014
|
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4139185/ https://www.ncbi.nlm.nih.gov/pubmed/25052294 http://dx.doi.org/10.1021/ar500203h |